Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2b Study of PS-Omega3 Conjugate Supplementation to ADHD Diagnosed Children

NCT00700323 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT00700323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00700323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2b Study of PS-Omega3 Conjugate Supplementation to ADHD Diagnosed Children
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2008
Completion date
July 31, 2009
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd